VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q66732113 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241120235922.0
008 241120nneanz||abbn n and d
035 ‎‡a (WKP)Q66732113‏
035 ‎‡a (OCoLC)Q66732113‏
100 0 ‎‡a David I Watkins‏ ‎‡9 en‏ ‎‡9 nl‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a ডেভিড আই ওয়াটকিন্স‏ ‎‡9 bn‏
670 ‎‡a Author's A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation‏
670 ‎‡a Author's A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus‏
670 ‎‡a Author's A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques‏
670 ‎‡a Author's A shared MHC supertype motif emerges by convergent evolution in macaques and mice, but is totally absent in human MHC molecules‏
670 ‎‡a Author's A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge‏
670 ‎‡a Author's Acute HIV infection with rapid progression to AIDS.‏
670 ‎‡a Author's Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection‏
670 ‎‡a Author's AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape‏
670 ‎‡a Author's Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes‏
670 ‎‡a Author's Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag‏
670 ‎‡a Author's Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications.‏
670 ‎‡a Author's Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers‏
670 ‎‡a Author's Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L‏
670 ‎‡a Author's CD8 + T Cell Recognition of Cryptic Epitopes Is a Ubiquitous Feature of AIDS Virus Infection‏
670 ‎‡a Author's CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5-7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses‏
670 ‎‡a Author's CD8+ T cell escape mutations in simian immunodeficiency virus SIVmac239 cause fitness defects in vivo, and many revert after transmission‏
670 ‎‡a Author's CD8+ T cell recognition of cryptic epitopes is a ubiquitous feature of AIDS virus infection‏
670 ‎‡a Author's CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation‏
670 ‎‡a Author's CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little‏
670 ‎‡a Author's Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons‏
670 ‎‡a Author's Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity‏
670 ‎‡a Author's Characterization of the peptide-binding specificity of Mamu-B*17 and identification of Mamu-B*17-restricted epitopes derived from simian immunodeficiency virus proteins‏
670 ‎‡a Author's Chinese origin rhesus macaque major histocompatibility complex class I molecules promiscuously present epitopes from SIV associated with molecules of Indian origin; implications for immunodominance and viral escape‏
670 ‎‡a Author's Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model‏
670 ‎‡a Author's Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL.‏
670 ‎‡a Author's Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques‏
670 ‎‡a Author's Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts‏
670 ‎‡a Author's Cytotoxic capacity of SIV-specific CD8‏
670 ‎‡a Author's Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques‏
670 ‎‡a Author's Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial‏
670 ‎‡a Author's Cytotoxic T-lymphocyte escape monitoring in simian immunodeficiency virus vaccine challenge studies‏
670 ‎‡a Author's Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys‏
670 ‎‡a Author's Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques‏
670 ‎‡a Author's Differences between T cell epitopes recognized after immunization and after infection‏
670 ‎‡a Author's Differential antigen presentation kinetics of CD8+ T-cell epitopes derived from the same viral protein‏
670 ‎‡a Author's DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells‏
670 ‎‡a Author's Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection‏
670 ‎‡a Author's Effective simian immunodeficiency virus-specific CD8+ T cells lack an easily detectable, shared characteristic‏
670 ‎‡a Author's Effects of cytotoxic T lymphocytes‏
670 ‎‡a Author's Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection‏
670 ‎‡a Author's Efficacy of multivalent adenovirus-based vaccine against simian immunodeficiency virus challenge‏
670 ‎‡a Author's Escape from CD8‏
670 ‎‡a Author's Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers‏
670 ‎‡a Author's Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?‏
670 ‎‡a Author's Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication‏
670 ‎‡a Author's Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response‏
670 ‎‡a Author's Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques.‏
670 ‎‡a Author's Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection‏
670 ‎‡a Author's Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression‏
670 ‎‡a Author's GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivo‏
670 ‎‡a Author's Genomic epidemiology reveals multiple introductions of Zika virus into the United States‏
670 ‎‡a Author's Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Basic HIV vaccine development.‏
670 ‎‡a Author's Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo‏
670 ‎‡a Author's HIV and SIV CTL escape: implications for vaccine design‏
670 ‎‡a Author's HIV pathogenesis: the first cut is the deepest.‏
670 ‎‡a Author's HIV vaccine design: insights from live attenuated SIV vaccines‏
670 ‎‡a Author's Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition‏
670 ‎‡a Author's Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus‏
670 ‎‡a Author's Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f‏
670 ‎‡a Author's Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques.‏
670 ‎‡a Author's Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques‏
670 ‎‡a Author's Impact of MHC class I diversity on immune control of immunodeficiency virus replication‏
670 ‎‡a Author's Improved genetic stability of recombinant yellow fever 17D virus expressing a lentiviral Gag gene fragment‏
670 ‎‡a Author's Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge‏
670 ‎‡a Author's Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques‏
670 ‎‡a Author's Is an HIV vaccine possible?‏
670 ‎‡a Author's Localized populations of CD8 MHC class I tetramer SIV-specific T cells in lymphoid follicles and genital epithelium‏
670 ‎‡a Author's Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine‏
670 ‎‡a Author's Macaques vaccinated with live-attenuated SIV control replication of heterologous virus‏
670 ‎‡a Author's Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge‏
670 ‎‡a Author's Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses‏
670 ‎‡a Author's Mamu-B*08-positive macaques control simian immunodeficiency virus replication‏
670 ‎‡a Author's MHC polymorphism: AIDS susceptibility in non-human primates‏
670 ‎‡a Author's Multiple introductions of Zika virus into the United States revealed through genomic epidemiology‏
670 ‎‡a Author's Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.‏
670 ‎‡a Author's Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing‏
670 ‎‡a Author's Nomenclature report on the major histocompatibility complex genes and alleles of Great Ape, Old and New World monkey species‏
670 ‎‡a Author's Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans‏
670 ‎‡a Author's Not all cytokine-producing CD8+ T cells suppress simian immunodeficiency virus replication‏
670 ‎‡a Author's Novel translation products from simian immunodeficiency virus SIVmac239 Env-encoding mRNA contain both Rev and cryptic T-cell epitopes‏
670 ‎‡a Author's Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL.‏
670 ‎‡a Author's Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication‏
670 ‎‡a Author's Pol-specific CD8+ T cells recognize simian immunodeficiency virus-infected cells prior to Nef-mediated major histocompatibility complex class I downregulation‏
670 ‎‡a Author's Polymorphisms in eight host genes associated with control of HIV replication do not mediate elite control of viral replication in SIV-infected Indian rhesus macaques‏
670 ‎‡a Author's Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine‏
670 ‎‡a Author's Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection‏
670 ‎‡a Author's Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine‏
670 ‎‡a Author's Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans‏
670 ‎‡a Author's Protection against high-dose highly pathogenic mucosal SIV challenge at very low serum neutralizing titers of the antibody-like molecule CD4-IgG2.‏
670 ‎‡a Author's Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection‏
670 ‎‡a Author's Public health. A sound rationale needed for phase III HIV-1 vaccine trials‏
670 ‎‡a Author's Pyrosequencing reveals restricted patterns of CD8+ T cell escape-associated compensatory mutations in simian immunodeficiency virus‏
670 ‎‡a Author's Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost‏
670 ‎‡a Author's Rare Control of SIVmac239 Infection in a Vaccinated Rhesus Macaque‏
670 ‎‡a Author's Recognition of escape variants in ELISPOT does not always predict CD8+ T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences‏
670 ‎‡a Author's Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8+ T-Cell Responses in Rhesus Macaques‏
670 ‎‡a Author's Reduction of CD4+ T cells in vivo does not affect virus load in macaque elite controllers‏
670 ‎‡a Author's Relevance of studying T cell responses in SIV-infected rhesus macaques‏
670 ‎‡a Author's Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates‏
670 ‎‡a Author's Reversion of CTL escape–variant immunodeficiency viruses in vivo‏
670 ‎‡a Author's Rhesus Macaques Vaccinated with,, and Manifest Early Control of SIVmac239 Replication‏
670 ‎‡a Author's Robust, vaccine-induced CD8(+) T lymphocyte response against an out-of-frame epitope‏
670 ‎‡a Author's Simian immunodeficiency virus-specific CD4+ T cells from successful vaccinees target the SIV Gag capsid‏
670 ‎‡a Author's Simian T Lymphotropic Virus 1 Infection of Papio anubis: tax Sequence Heterogeneity and T Cell Recognition‏
670 ‎‡a Author's Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication‏
670 ‎‡a Author's Synchronous infection of SIV and HIV in vitro for virology, immunology and vaccine-related studies‏
670 ‎‡a Author's T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge‏
670 ‎‡a Author's Tat(28-35)SL8-specific CD8+ T lymphocytes are more effective than Gag(181-189)CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assay‏
670 ‎‡a Author's Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication‏
670 ‎‡a Author's The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape‏
670 ‎‡a Author's The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication‏
670 ‎‡a Author's The hope for an HIV vaccine based on induction of CD8+ T lymphocytes--a review‏
670 ‎‡a Author's The live-attenuated yellow fever vaccine 17D induces broad and potent T cell responses against several viral proteins in Indian rhesus macaques--implications for recombinant vaccine design‏
670 ‎‡a Author's The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers‏
670 ‎‡a Author's The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages‏
670 ‎‡a Author's The pigtail macaque MHC class I allele Mane-A*10 presents an immundominant SIV Gag epitope: identification, tetramer development and implications of immune escape and reversion.‏
670 ‎‡a Author's The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection‏
670 ‎‡a Author's The role of MHC class I gene products in SIV infection of macaques‏
670 ‎‡a Author's The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challenge‏
670 ‎‡a Author's Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity‏
670 ‎‡a Author's Understanding animal models of elite control: windows on effective immune responses against immunodeficiency viruses‏
670 ‎‡a Author's Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication‏
670 ‎‡a Author's Unparalleled complexity of the MHC class I region in rhesus macaques‏
670 ‎‡a Author's Update on progress in HIV vaccine development.‏
670 ‎‡a Author's Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys‏
670 ‎‡a Author's Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239‏
670 ‎‡a Author's Vaccine-induced CD8+ T cells control AIDS virus replication‏
670 ‎‡a Author's Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239‏
670 ‎‡a Author's Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge‏
670 ‎‡a Author's Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection‏
670 ‎‡a Author's Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques‏
670 ‎‡a Author's Wanted: correlates of vaccine-induced protection against simian immunodeficiency virus‏
670 ‎‡a Author's What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Rigorous Simian Immunodeficiency Virus Vaccine Trials Can Be Instructive‏
670 ‎‡a Author's Within-host evolution of CD8+-TL epitopes encoded by overlapping and non-overlapping reading frames of simian immunodeficiency virus‏
670 ‎‡a Author's Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network‏
670 ‎‡a Author's Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice‏
912 ‎‡a genomicepidemiologyrevealsmultipleintroductionsofzikavirusintotheunitedstates‏ ‎‡A Genomic epidemiology reveals multiple introductions of Zika virus into the United States‏ ‎‡9 1‏
912 ‎‡a multipleintroductionsofzikavirusintotheunitedstatesrevealedthroughgenomicepidemiology‏ ‎‡A Multiple introductions of Zika virus into the United States revealed through genomic epidemiology‏ ‎‡9 1‏
919 ‎‡a highlightsofthe15conferenceonretrovirusesandopportunisticinfectionsbasichivvaccinedevelopment‏ ‎‡A Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Basic HIV vaccine development.‏ ‎‡9 1‏
919 ‎‡a dominantroleforcd8+tlymphocyteselectioninsimianimmunodeficiencyvirussequencevariation‏ ‎‡A A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation‏ ‎‡9 1‏
919 ‎‡a humaninferredgermlineantibodybindstoanimmunodominantepitopeandneutralizeszikavirus‏ ‎‡A A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus‏ ‎‡9 1‏
919 ‎‡a nonfucosylatedvariantoftheantihiv1monoclonalantibodyb12hasenhancedfcγriiiamediatedantiviralactivityinvitrobutdoesnotimproveprotectionagainstmucosalshivchallengeinmacaques‏ ‎‡A A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques‏ ‎‡9 1‏
919 ‎‡a sharedmhcsupertypemotifemergesbyconvergentevolutioninmacaquesandmicebutistotallyabsentinhumanmhcmolecules‏ ‎‡A A shared MHC supertype motif emerges by convergent evolution in macaques and mice, but is totally absent in human MHC molecules‏ ‎‡9 1‏
919 ‎‡a trivalentrecombinantad5gagpolnefvaccinefailstoprotectrhesusmacaquesfrominfectionorcontrolvirusreplicationafteralimitingdoseheterologoussivchallenge‏ ‎‡A A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge‏ ‎‡9 1‏
919 ‎‡a acutehivinfectionwithrapidprogressiontoaids‏ ‎‡A Acute HIV infection with rapid progression to AIDS.‏ ‎‡9 1‏
919 ‎‡a acutephasecytotoxictlymphocyteescapeisahallmarkofsimianimmunodeficiencyvirusinfection‏ ‎‡A Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection‏ ‎‡9 1‏
919 ‎‡a aidsvirusspecificcd8+tlymphocytesagainstanimmunodominantcrypticepitopeselectforviralescape‏ ‎‡A AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape‏ ‎‡9 1‏
919 ‎‡a analysisofpigtailmacaquemajorhistocompatibilitycomplexclass1moleculespresentingimmunodominantsimianimmunodeficiencyvirusepitopes‏ ‎‡A Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes‏ ‎‡9 1‏
919 ‎‡a attenuationofsimianimmunodeficiencyvirussivmac239infectionbyprophylacticimmunizationwithdnaandrecombinantadenoviralvaccinevectorsexpressinggag‏ ‎‡A Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag‏ ‎‡9 1‏
919 ‎‡a automatedgenerationandevaluationofspecificmhcbindingpredictivetoolsarbmatrixapplications‏ ‎‡A Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications.‏ ‎‡9 1‏
919 ‎‡a broadlyneutralizinghumanantihivantibody2g12iseffectiveinprotectionagainstmucosalshivchallengeevenatlowserumneutralizingtiters‏ ‎‡A Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers‏ ‎‡9 1‏
919 ‎‡a broadlyneutralizingmonoclonalantibodies2f5and4e10directedagainstthehumanimmunodeficiencyvirustype1gp41membraneproximalexternalregionprotectagainstmucosalchallengebysimianhumanimmunodeficiencyvirusshivba50‏ ‎‡A Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L‏ ‎‡9 1‏
919 ‎‡a cd8+tcellrecognitionofcrypticepitopesisaubiquitousfeatureofaidsvirusinfection‏ ‎‡A CD8 + T Cell Recognition of Cryptic Epitopes Is a Ubiquitous Feature of AIDS Virus Infection‏ ‎‡9 2‏
919 ‎‡a cd8+gammadeltatcr+andcd4+tcellsproduceifnγat57daysafteryellowfevervaccinationinindianrhesusmacaquesbeforetheinductionofclassicalantigenspecifictcellresponses‏ ‎‡A CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5-7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses‏ ‎‡9 1‏
919 ‎‡a cd8+tcellescapemutationsinsimianimmunodeficiencyvirussivmac239causefitnessdefectsinvivoandmanyrevertaftertransmission‏ ‎‡A CD8+ T cell escape mutations in simian immunodeficiency virus SIVmac239 cause fitness defects in vivo, and many revert after transmission‏ ‎‡9 1‏
919 ‎‡a cd8+tcellsfromsivelitecontrollermacaquesrecognizemamub08boundepitopesandselectforwidespreadviralvariation‏ ‎‡A CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation‏ ‎‡9 1‏
919 ‎‡a cd8+tlymphocyteresponsetomajorimmunodominantepitopesaftervaginalexposuretosimianimmunodeficiencyvirustoolateandtoolittle‏ ‎‡A CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little‏ ‎‡9 1‏
919 ‎‡a cellularimmuneresponsesagainstsimiantlymphotropicvirustype1targettaxininfectedbaboons‏ ‎‡A Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons‏ ‎‡9 1‏
919 ‎‡a characterizationofthepeptidebindingspecificityofmamua11resultsintheidentificationofsivderivedepitopesandinterspeciescrossreactivity‏ ‎‡A Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity‏ ‎‡9 1‏
919 ‎‡a characterizationofthepeptidebindingspecificityofmamub17andidentificationofmamub17restrictedepitopesderivedfromsimianimmunodeficiencyvirusproteins‏ ‎‡A Characterization of the peptide-binding specificity of Mamu-B*17 and identification of Mamu-B*17-restricted epitopes derived from simian immunodeficiency virus proteins‏ ‎‡9 1‏
919 ‎‡a chineseoriginrhesusmacaquemajorhistocompatibilitycomplexclass1moleculespromiscuouslypresentepitopesfromsivassociatedwithmoleculesofindianoriginimplicationsforimmunodominanceandviralescape‏ ‎‡A Chinese origin rhesus macaque major histocompatibility complex class I molecules promiscuously present epitopes from SIV associated with molecules of Indian origin; implications for immunodominance and viral escape‏ ‎‡9 1‏
919 ‎‡a comparisonofvaccinestrategiesusingrecombinantenvgagpolmvawithorwithoutanoligomericenvproteinboostintheshivrhesusmacaquemodel‏ ‎‡A Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model‏ ‎‡9 1‏
919 ‎‡a compartmentalizationofsimianimmunodeficiencyvirusreplicationwithinsecondarylymphoidtissuesofrhesusmacaquesislinkedtodiseasestageandinverselyrelatedtolocalizationofvirusspecificctl‏ ‎‡A Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL.‏ ‎‡9 1‏
919 ‎‡a comprehensiveimmunologicalevaluationrevealssurprisinglyfewdifferencesbetweenelitecontrollerandprogressormamub17positivesimianimmunodeficiencyvirusinfectedrhesusmacaques‏ ‎‡A Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques‏ ‎‡9 1‏
919 ‎‡a consequencesofcytotoxictlymphocyteescapecommonescapemutationsinsimianimmunodeficiencyvirusarepoorlyrecognizedinnaivehosts‏ ‎‡A Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts‏ ‎‡9 1‏
919 ‎‡a cytotoxiccapacityofsivspecificcd8‏ ‎‡A Cytotoxic capacity of SIV-specific CD8‏ ‎‡9 1‏
919 ‎‡a cytotoxiccapacityofsivspecificcd8+tcellsagainstprimaryautologoustargetscorrelateswithimmunecontrolinsivinfectedrhesusmacaques‏ ‎‡A Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques‏ ‎‡9 1‏
919 ‎‡a cytotoxictlymphocytebasedcontrolofsimianimmunodeficiencyvirusreplicationinapreclinicalaidsvaccinetrial‏ ‎‡A Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial‏ ‎‡9 1‏
919 ‎‡a cytotoxictlymphocyteescapemonitoringinsimianimmunodeficiencyvirusvaccinechallengestudies‏ ‎‡A Cytotoxic T-lymphocyte escape monitoring in simian immunodeficiency virus vaccine challenge studies‏ ‎‡9 1‏
919 ‎‡a denguevirusevadesaavmediatedneutralizingantibodyprophylaxisinrhesusmonkeys‏ ‎‡A Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys‏ ‎‡9 1‏
919 ‎‡a denguevirusspecificcd4+andcd8+tlymphocytestargetns1ns3andns5ininfectedindianrhesusmacaques‏ ‎‡A Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques‏ ‎‡9 1‏
919 ‎‡a differencesbetweentcellepitopesrecognizedafterimmunizationandafterinfection‏ ‎‡A Differences between T cell epitopes recognized after immunization and after infection‏ ‎‡9 1‏
919 ‎‡a differentialantigenpresentationkineticsofcd8+tcellepitopesderivedfromthesameviralprotein‏ ‎‡A Differential antigen presentation kinetics of CD8+ T-cell epitopes derived from the same viral protein‏ ‎‡9 1‏
919 ‎‡a dnaad5vaccinationwithsivepitopesinducedepitopespecificcd4+tcellsbutfewsubdominantepitopespecificcd8+tcells‏ ‎‡A DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells‏ ‎‡9 1‏
919 ‎‡a dominanceofcd8responsesspecificforepitopesboundbyasinglemajorhistocompatibilitycomplexclass1moleculeduringtheacutephaseofviralinfection‏ ‎‡A Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection‏ ‎‡9 1‏
919 ‎‡a effectivesimianimmunodeficiencyvirusspecificcd8+tcellslackaneasilydetectablesharedcharacteristic‏ ‎‡A Effective simian immunodeficiency virus-specific CD8+ T cells lack an easily detectable, shared characteristic‏ ‎‡9 1‏
919 ‎‡a effectsofcytotoxictlymphocytes‏ ‎‡A Effects of cytotoxic T lymphocytes‏ ‎‡9 1‏
919 ‎‡a effectsofcytotoxictlymphocytesctldirectedagainstasinglesimianimmunodeficiencyvirussivgagctlepitopeonthecourseofsivmac239infection‏ ‎‡A Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection‏ ‎‡9 1‏
919 ‎‡a efficacyofmultivalentadenovirusbasedvaccineagainstsimianimmunodeficiencyviruschallenge‏ ‎‡A Efficacy of multivalent adenovirus-based vaccine against simian immunodeficiency virus challenge‏ ‎‡9 1‏
919 ‎‡a escapefromcd8‏ ‎‡A Escape from CD8‏ ‎‡9 1‏
919 ‎‡a escapefromcd8+tcellresponsesinmamub00801+macaquesdifferentiatesprogressorsfromelitecontrollers‏ ‎‡A Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers‏ ‎‡9 1‏
919 ‎‡a escapein1of2cytotoxictlymphocyteepitopesboundbyahighfrequencymajorhistocompatibilitycomplexclass1moleculemamua02aparadigmforvirusevolutionandpersistence‏ ‎‡A Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?‏ ‎‡9 1‏
919 ‎‡a expressionofthemajorhistocompatibilitycomplexclass1moleculemamua01isassociatedwithcontrolofsimianimmunodeficiencyvirussivmac239replication‏ ‎‡A Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication‏ ‎‡9 1‏
919 ‎‡a extraepitopiccompensatorysubstitutionspartiallyrestorefitnesstosimianimmunodeficiencyvirusvariantsthatescapefromanimmunodominantcytotoxictlymphocyteresponse‏ ‎‡A Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response‏ ‎‡9 1‏
919 ‎‡a fetaldemiseandfailedantibodytherapyduringzikavirusinfectionofpregnantmacaques‏ ‎‡A Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques.‏ ‎‡9 1‏
919 ‎‡a gagandnefspecificcd4+tcellsrecognizeandinhibitsivreplicationininfectedmacrophagesearlyafterinfection‏ ‎‡A Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection‏ ‎‡9 1‏
919 ‎‡a gagspecificcd8+tlymphocytesrecognizeinfectedcellsbeforeaidsvirusintegrationandviralproteinexpression‏ ‎‡A Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression‏ ‎‡9 1‏
919 ‎‡a gagcm9specificcd8+tcellsexpressinglimitedpublictcrclonotypesdonotsuppresssivreplicationinvivo‏ ‎‡A GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivo‏ ‎‡9 1‏
919 ‎‡a highlypotenthivspecificantibodyneutralizationinvitrotranslatesintoeffectiveprotectionagainstmucosalshivchallengeinvivo‏ ‎‡A Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo‏ ‎‡9 1‏
919 ‎‡a hivandsivctlescapeimplicationsforvaccinedesign‏ ‎‡A HIV and SIV CTL escape: implications for vaccine design‏ ‎‡9 1‏
919 ‎‡a hivpathogenesisthe1cutisthedeepest‏ ‎‡A HIV pathogenesis: the first cut is the deepest.‏ ‎‡9 1‏
919 ‎‡a hivvaccinedesigninsightsfromliveattenuatedsivvaccines‏ ‎‡A HIV vaccine design: insights from live attenuated SIV vaccines‏ ‎‡9 1‏
919 ‎‡a identificationof17newsimianimmunodeficiencyvirusderivedcd8+tcellepitopesrestrictedbythehighfrequencymoleculemamua02andpotentialescapefromctlrecognition‏ ‎‡A Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition‏ ‎‡9 1‏
919 ‎‡a immunizationofrhesusmacaqueswithadnaprimemodifiedvacciniavirusankaraboostregimeninducesbroadsimianimmunodeficiencyvirus‏ ‎‡A Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus‏ ‎‡9 1‏
919 ‎‡a immunizationofrhesusmacaqueswithadnaprimemodifiedvacciniavirusankaraboostregimeninducesbroadsimianimmunodeficiencyvirussivspecifictcellresponsesandreducesinitialviralreplicationbutdoesnotpreventdiseaseprogressionf‏ ‎‡A Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f‏ ‎‡9 1‏
919 ‎‡a immunogenicityofhybriddnavaccinesexpressinghepatitisbcoreparticlescarryinghumanandsimianimmunodeficiencyvirusepitopesinmiceandrhesusmacaques‏ ‎‡A Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques.‏ ‎‡9 1‏
919 ‎‡a immunogenicityof7newrecombinantyellowfeverviruses17dexpressingfragmentsofsivmac239gagnefandvifinindianrhesusmacaques‏ ‎‡A Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques‏ ‎‡9 1‏
919 ‎‡a impactofmhcclass1diversityonimmunecontrolofimmunodeficiencyvirusreplication‏ ‎‡A Impact of MHC class I diversity on immune control of immunodeficiency virus replication‏ ‎‡9 1‏
919 ‎‡a improvedgeneticstabilityofrecombinantyellowfever17dvirusexpressingalentiviralgaggenefragment‏ ‎‡A Improved genetic stability of recombinant yellow fever 17D virus expressing a lentiviral Gag gene fragment‏ ‎‡9 1‏
919 ‎‡a inductionofantisimianimmunodeficiencyviruscellularandhumoralimmuneresponsesinrhesusmacaquesbypeptideimmunogenscorrelationofctlactivityandreductionofcellassociatedbutnotplasmavirusloadfollowingchallenge‏ ‎‡A Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge‏ ‎‡9 1‏
919 ‎‡a infectionwithescapedvirusvariantsimpairscontrolofsimianimmunodeficiencyvirussivmac239replicationinmamub08positivemacaques‏ ‎‡A Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques‏ ‎‡9 1‏
919 ‎‡a isanhivvaccinepossible‏ ‎‡A Is an HIV vaccine possible?‏ ‎‡9 1‏
919 ‎‡a localizedpopulationsofcd8mhcclass1tetramersivspecifictcellsinlymphoidfolliclesandgenitalepithelium‏ ‎‡A Localized populations of CD8 MHC class I tetramer SIV-specific T cells in lymphoid follicles and genital epithelium‏ ‎‡9 1‏
919 ‎‡a longtermcontrolofsimianimmunodeficiencyvirusreplicationwithcentralmemorycd4+tcellpreservationafternonsterileprotectionbyacytotoxictlymphocytebasedvaccine‏ ‎‡A Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine‏ ‎‡9 1‏
919 ‎‡a macaquesvaccinatedwithliveattenuatedsivcontrolreplicationofheterologousvirus‏ ‎‡A Macaques vaccinated with live-attenuated SIV control replication of heterologous virus‏ ‎‡9 1‏
919 ‎‡a macaquesvaccinatedwithsimianimmunodeficiencyvirussivmac239deltanefdelayacquisitionandcontrolreplicationafterrepeatedlowdoseheterologoussivchallenge‏ ‎‡A Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge‏ ‎‡9 1‏
919 ‎‡a majorhistocompatibilitycomplexclass1allelesassociatedwithslowsimianimmunodeficiencyvirusdiseaseprogressionbindepitopesrecognizedbydominantacutephasecytotoxictlymphocyteresponses‏ ‎‡A Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses‏ ‎‡9 1‏
919 ‎‡a mamub08positivemacaquescontrolsimianimmunodeficiencyvirusreplication‏ ‎‡A Mamu-B*08-positive macaques control simian immunodeficiency virus replication‏ ‎‡9 1‏
919 ‎‡a mhcpolymorphismaidssusceptibilityinnonhumanprimates‏ ‎‡A MHC polymorphism: AIDS susceptibility in non-human primates‏ ‎‡9 1‏
919 ‎‡a multispecificvaccineinducedmucosalcytotoxictlymphocytesreduceacutephaseviralreplicationbutfailinlongtermcontrolofsimianimmunodeficiencyvirussivmac239‏ ‎‡A Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.‏ ‎‡9 1‏
919 ‎‡a nefisdispensableforresistanceofsimianimmunodeficiencyvirusinfectedmacrophagestocd8+tcellkilling‏ ‎‡A Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing‏ ‎‡9 1‏
919 ‎‡a nomenclaturereportonthemajorhistocompatibilitycomplexgenesandallelesofgreatapeoldandnewworldmonkeyspecies‏ ‎‡A Nomenclature report on the major histocompatibility complex genes and alleles of Great Ape, Old and New World monkey species‏ ‎‡9 1‏
919 ‎‡a nonhumanprimatemodelsandthefailureofthemerckhiv1vaccineinhumans‏ ‎‡A Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans‏ ‎‡9 1‏
919 ‎‡a notallcytokineproducingcd8+tcellssuppresssimianimmunodeficiencyvirusreplication‏ ‎‡A Not all cytokine-producing CD8+ T cells suppress simian immunodeficiency virus replication‏ ‎‡9 1‏
919 ‎‡a noveltranslationproductsfromsimianimmunodeficiencyvirussivmac239envencodingmrnacontainbothrevandcryptictcellepitopes‏ ‎‡A Novel translation products from simian immunodeficiency virus SIVmac239 Env-encoding mRNA contain both Rev and cryptic T-cell epitopes‏ ‎‡9 1‏
919 ‎‡a ontogenyofthebandtcellresponseinaprimaryzikavirusinfectionofadenguenaiveindividualduringthe2016outbreakinmiamifl‏ ‎‡A Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL.‏ ‎‡9 1‏
919 ‎‡a patternsofcd8+immunodominancemayinfluencetheabilityofmamub08positivemacaquestonaturallycontrolsimianimmunodeficiencyvirussivmac239replication‏ ‎‡A Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication‏ ‎‡9 1‏
919 ‎‡a polspecificcd8+tcellsrecognizesimianimmunodeficiencyvirusinfectedcellspriortonefmediatedmajorhistocompatibilitycomplexclass1downregulation‏ ‎‡A Pol-specific CD8+ T cells recognize simian immunodeficiency virus-infected cells prior to Nef-mediated major histocompatibility complex class I downregulation‏ ‎‡9 1‏
919 ‎‡a polymorphismsin8hostgenesassociatedwithcontrolofhivreplicationdonotmediateelitecontrolofviralreplicationinsivinfectedindianrhesusmacaques‏ ‎‡A Polymorphisms in eight host genes associated with control of HIV replication do not mediate elite control of viral replication in SIV-infected Indian rhesus macaques‏ ‎‡9 1‏
919 ‎‡a potentplasmablastderivedantibodieselicitedbythenationalinstitutesofhealthdenguevaccine‏ ‎‡A Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine‏ ‎‡9 1‏
919 ‎‡a prematureinductionofanimmunosuppressiveregulatorytcellresponseduringacutesimianimmunodeficiencyvirusinfection‏ ‎‡A Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection‏ ‎‡9 1‏
919 ‎‡a preventionofdiseaseinducedbyapartiallyheterologousaidsvirusinrhesusmonkeysbyusinganadjuvantedmulticomponentproteinvaccine‏ ‎‡A Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine‏ ‎‡9 1‏
919 ‎‡a priordenguevirusexposureshapestcellimmunitytozikavirusinhumans‏ ‎‡A Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans‏ ‎‡9 1‏
919 ‎‡a protectionagainsthighdosehighlypathogenicmucosalsivchallengeatverylowserumneutralizingtitersoftheantibodylikemoleculecd4igg2‏ ‎‡A Protection against high-dose highly pathogenic mucosal SIV challenge at very low serum neutralizing titers of the antibody-like molecule CD4-IgG2.‏ ‎‡9 1‏
919 ‎‡a publicclonotypeusageidentifiesprotectivegagspecificcd8+tcellresponsesinsivinfection‏ ‎‡A Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection‏ ‎‡9 1‏
919 ‎‡a publichealthasoundrationaleneededforphase3hiv1vaccinetrials‏ ‎‡A Public health. A sound rationale needed for phase III HIV-1 vaccine trials‏ ‎‡9 1‏
919 ‎‡a pyrosequencingrevealsrestrictedpatternsofcd8+tcellescapeassociatedcompensatorymutationsinsimianimmunodeficiencyvirus‏ ‎‡A Pyrosequencing reveals restricted patterns of CD8+ T cell escape-associated compensatory mutations in simian immunodeficiency virus‏ ‎‡9 1‏
919 ‎‡a rapidviralescapeatanimmunodominantsimianhumanimmunodeficiencyviruscytotoxictlymphocyteepitopeexactsadramaticfitnesscost‏ ‎‡A Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost‏ ‎‡9 1‏
919 ‎‡a rarecontrolofsivmac239infectioninavaccinatedrhesusmacaque‏ ‎‡A Rare Control of SIVmac239 Infection in a Vaccinated Rhesus Macaque‏ ‎‡9 1‏
919 ‎‡a recognitionofescapevariantsinelispotdoesnotalwayspredictcd8+tcellrecognitionofsimianimmunodeficiencyvirusinfectedcellsexpressingthesamevariantsequences‏ ‎‡A Recognition of escape variants in ELISPOT does not always predict CD8+ T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences‏ ‎‡9 1‏
919 ‎‡a recombinantyellowfevervaccinevirus17dexpressingsimianimmunodeficiencyvirussivmac239gaginducessivspecificcd8+tcellresponsesinrhesusmacaques‏ ‎‡A Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8+ T-Cell Responses in Rhesus Macaques‏ ‎‡9 1‏
919 ‎‡a reductionofcd4+tcellsinvivodoesnotaffectvirusloadinmacaqueelitecontrollers‏ ‎‡A Reduction of CD4+ T cells in vivo does not affect virus load in macaque elite controllers‏ ‎‡9 1‏
919 ‎‡a relevanceofstudyingtcellresponsesinsivinfectedrhesusmacaques‏ ‎‡A Relevance of studying T cell responses in SIV-infected rhesus macaques‏ ‎‡9 1‏
919 ‎‡a repeatedlowdosemucosalsimianimmunodeficiencyvirussivmac239challengeresultsinthesameviralandimmunologicalkineticsashighdosechallengeamodelfortheevaluationofvaccineefficacyinnonhumanprimates‏ ‎‡A Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates‏ ‎‡9 1‏
919 ‎‡a reversionofctlescapevariantimmunodeficiencyvirusesinvivo‏ ‎‡A Reversion of CTL escape–variant immunodeficiency viruses in vivo‏ ‎‡9 1‏
919 ‎‡a rhesusmacaquesvaccinatedwithandmanifestearlycontrolofsivmac239replication‏ ‎‡A Rhesus Macaques Vaccinated with,, and Manifest Early Control of SIVmac239 Replication‏ ‎‡9 1‏
919 ‎‡a robustvaccineinducedcd8+tlymphocyteresponseagainstanoutofframeepitope‏ ‎‡A Robust, vaccine-induced CD8(+) T lymphocyte response against an out-of-frame epitope‏ ‎‡9 1‏
919 ‎‡a simianimmunodeficiencyvirusspecificcd4+tcellsfromsuccessfulvaccineestargetthesivgagcapsid‏ ‎‡A Simian immunodeficiency virus-specific CD4+ T cells from successful vaccinees target the SIV Gag capsid‏ ‎‡9 1‏
919 ‎‡a simiantlymphotropicvirus1infectionofpapioanubistaxsequenceheterogeneityandtcellrecognition‏ ‎‡A Simian T Lymphotropic Virus 1 Infection of Papio anubis: tax Sequence Heterogeneity and T Cell Recognition‏ ‎‡9 1‏
919 ‎‡a subdominantcd8+tcellresponsesareinvolvedindurablecontrolofaidsvirusreplication‏ ‎‡A Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication‏ ‎‡9 1‏
919 ‎‡a synchronousinfectionofsivandhivinvitroforvirologyimmunologyandvaccinerelatedstudies‏ ‎‡A Synchronous infection of SIV and HIV in vitro for virology, immunology and vaccine-related studies‏ ‎‡9 1‏
919 ‎‡a tcellcorrelatesofvaccineefficacyafteraheterologoussimianimmunodeficiencyviruschallenge‏ ‎‡A T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge‏ ‎‡9 1‏
919 ‎‡a tat2835sl8specificcd8+tlymphocytesaremoreeffectivethangag181189cm9specificcd8+tlymphocytesatsuppressingsimianimmunodeficiencyvirusreplicationinafunctionalinvitroassay‏ ‎‡A Tat(28-35)SL8-specific CD8+ T lymphocytes are more effective than Gag(181-189)CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assay‏ ‎‡9 1‏
919 ‎‡a tatvaccinatedmacaquesdonotcontrolsimianimmunodeficiencyvirussivmac239replication‏ ‎‡A Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication‏ ‎‡9 1‏
919 ‎‡a antiviralefficacyofsimianimmunodeficiencyvirusspecificcd8+tcellsisunrelatedtoepitopespecificityandisabrogatedbyviralescape‏ ‎‡A The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape‏ ‎‡9 1‏
919 ‎‡a highfrequencymajorhistocompatibilitycomplexclass1allelemamub17isassociatedwithcontrolofsimianimmunodeficiencyvirussivmac239replication‏ ‎‡A The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication‏ ‎‡9 1‏
919 ‎‡a hopeforanhivvaccinebasedoninductionofcd8+tlymphocytesareview‏ ‎‡A The hope for an HIV vaccine based on induction of CD8+ T lymphocytes--a review‏ ‎‡9 1‏
919 ‎‡a liveattenuatedyellowfevervaccine17dinducesbroadandpotenttcellresponsesagainstseveralviralproteinsinindianrhesusmacaquesimplicationsforrecombinantvaccinedesign‏ ‎‡A The live-attenuated yellow fever vaccine 17D induces broad and potent T cell responses against several viral proteins in Indian rhesus macaques--implications for recombinant vaccine design‏ ‎‡9 1‏
919 ‎‡a majorhistocompatibilitycomplexclass2allelesmamudrb11003anddrb10306areenrichedinacohortofsimianimmunodeficiencyvirusinfectedrhesusmacaqueelitecontrollers‏ ‎‡A The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers‏ ‎‡9 1‏
919 ‎‡a majorityoffreshlysortedsimianimmunodeficiencyvirussivspecificcd8+tcellscannotsuppressviralreplicationinsivinfectedmacrophages‏ ‎‡A The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages‏ ‎‡9 1‏
919 ‎‡a pigtailmacaquemhcclass1allelemanea10presentsanimmundominantsivgagepitopeidentificationtetramerdevelopmentandimplicationsofimmuneescapeandreversion‏ ‎‡A The pigtail macaque MHC class I allele Mane-A*10 presents an immundominant SIV Gag epitope: identification, tetramer development and implications of immune escape and reversion.‏ ‎‡9 1‏
919 ‎‡a roleofmhcclass1allelemamua07duringsivmac239infection‏ ‎‡A The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection‏ ‎‡9 1‏
919 ‎‡a roleofmhcclass1geneproductsinsivinfectionofmacaques‏ ‎‡A The role of MHC class I gene products in SIV infection of macaques‏ ‎‡9 1‏
919 ‎‡a trim5alphagenotypeofrhesusmacaquesaffectsacquisitionofsimianimmunodeficiencyvirussivsme660infectionafterrepeatedlimitingdoseintrarectalchallenge‏ ‎‡A The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challenge‏ ‎‡9 1‏
919 ‎‡a 2mhcclass1moleculesassociatedwithelitecontrolofimmunodeficiencyvirusreplicationmamub08andhlab2705bindpeptideswithsequencesimilarity‏ ‎‡A Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity‏ ‎‡9 1‏
919 ‎‡a understandinganimalmodelsofelitecontrolwindowsoneffectiveimmuneresponsesagainstimmunodeficiencyviruses‏ ‎‡A Understanding animal models of elite control: windows on effective immune responses against immunodeficiency viruses‏ ‎‡9 1‏
919 ‎‡a unexpecteddiversityofcellularimmuneresponsesagainstnefandvifinhiv1infectedpatientswhospontaneouslycontrolviralreplication‏ ‎‡A Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication‏ ‎‡9 1‏
919 ‎‡a unparalleledcomplexityofthemhcclass1regioninrhesusmacaques‏ ‎‡A Unparalleled complexity of the MHC class I region in rhesus macaques‏ ‎‡9 1‏
919 ‎‡a updateonprogressinhivvaccinedevelopment‏ ‎‡A Update on progress in HIV vaccine development.‏ ‎‡9 1‏
919 ‎‡a useofarecombinantgamma2herpesvirusvaccinevectoragainstdenguevirusinrhesusmonkeys‏ ‎‡A Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys‏ ‎‡9 1‏
919 ‎‡a vaccinationwithgagvifandnefgenefragmentsaffordspartialcontrolofviralreplicationaftermucosalchallengewithsivmac239‏ ‎‡A Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239‏ ‎‡9 1‏
919 ‎‡a vaccineinducedcd8+tcellscontrolaidsvirusreplication‏ ‎‡A Vaccine-induced CD8+ T cells control AIDS virus replication‏ ‎‡9 1‏
919 ‎‡a vaccineinducedcellularimmuneresponsesreduceplasmaviralconcentrationsafterrepeatedlowdosechallengewithpathogenicsimianimmunodeficiencyvirussivmac239‏ ‎‡A Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239‏ ‎‡9 1‏
919 ‎‡a vaccineinducedcellularresponsescontrolsimianimmunodeficiencyvirusreplicationafterheterologouschallenge‏ ‎‡A Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge‏ ‎‡9 1‏
919 ‎‡a vaccineinducedsimianimmunodeficiencyvirusspecificcd8+tcellresponsesfocusedonasinglenefepitopeselectforescapevariantsshortlyafterinfection‏ ‎‡A Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection‏ ‎‡9 1‏
919 ‎‡a viremiacontrolfollowingantiretroviraltreatmentandtherapeuticimmunizationduringprimarysiv251infectionofmacaques‏ ‎‡A Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques‏ ‎‡9 1‏
919 ‎‡a wantedcorrelatesofvaccineinducedprotectionagainstsimianimmunodeficiencyvirus‏ ‎‡A Wanted: correlates of vaccine-induced protection against simian immunodeficiency virus‏ ‎‡9 1‏
919 ‎‡a whatisthepredictivevalueofanimalmodelsforvaccineefficacyinhumansrigoroussimianimmunodeficiencyvirusvaccinetrialscanbeinstructive‏ ‎‡A What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Rigorous Simian Immunodeficiency Virus Vaccine Trials Can Be Instructive‏ ‎‡9 1‏
919 ‎‡a withinhostevolutionofcd8+tlepitopesencodedbyoverlappingandnonoverlappingreadingframesofsimianimmunodeficiencyvirus‏ ‎‡A Within-host evolution of CD8+-TL epitopes encoded by overlapping and non-overlapping reading frames of simian immunodeficiency virus‏ ‎‡9 1‏
919 ‎‡a zikaintheamericasyear2whathavewelearnedwhatgapsremainareportfromtheglobalvirusnetwork‏ ‎‡A Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network‏ ‎‡9 1‏
919 ‎‡a zikavirusimmuneplasmasfromsymptomaticandasymptomaticindividualsenhancezikapathogenesisinadultandpregnantmice‏ ‎‡A Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 LC|n 90689958‏
996 ‎‡2 ISNI|0000000368892159‏
996 ‎‡2 DNB|1189770997‏
996 ‎‡2 BIBSYS|1512647516762‏
996 ‎‡2 CAOONL|ncf11030567‏
996 ‎‡2 NII|DA01081245‏
996 ‎‡2 NTA|135394597‏
996 ‎‡2 BNF|12262943‏
996 ‎‡2 LC|nb2018022371‏
996 ‎‡2 LC|n 81017988‏
996 ‎‡2 RERO|A003959766‏
996 ‎‡2 RERO|A003959763‏
996 ‎‡2 LC|nb2018001099‏
996 ‎‡2 ISNI|0000000044316235‏
996 ‎‡2 DNB|139967877‏
996 ‎‡2 ISNI|0000000046599734‏
996 ‎‡2 BNF|15816709‏
996 ‎‡2 SUDOC|272964484‏
996 ‎‡2 LC|n 2013031877‏
996 ‎‡2 DNB|140906169‏
996 ‎‡2 ISNI|0000000080163547‏
996 ‎‡2 J9U|987007447370205171‏
996 ‎‡2 BIBSYS|9027822‏
996 ‎‡2 LC|n 82070096‏
996 ‎‡2 SUDOC|232942889‏
996 ‎‡2 J9U|987007449590405171‏
996 ‎‡2 LC|no2020146045‏
996 ‎‡2 LC|n 87834284‏
996 ‎‡2 RERO|A003977916‏
996 ‎‡2 BIBSYS|1542227323571‏
996 ‎‡2 ISNI|0000000355999301‏
996 ‎‡2 ISNI|0000000045267607‏
996 ‎‡2 LC|n 2007084063‏
996 ‎‡2 LC|no 96066801‏
996 ‎‡2 SUDOC|183326857‏
996 ‎‡2 DNB|134697987‏
996 ‎‡2 LC|n 94004521‏
996 ‎‡2 ISNI|0000000113469973‏
996 ‎‡2 BIBSYS|11058699‏
996 ‎‡2 LC|no2012010505‏
996 ‎‡2 NUKAT|n 2020069454‏
996 ‎‡2 ICCU|SBNV082793‏
996 ‎‡2 LIH|LNB:CMY_r_;=B_x_‏
996 ‎‡2 NSK|000636010‏
996 ‎‡2 ICCU|PUVV148072‏
996 ‎‡2 NUKAT|n 2018265436‏
996 ‎‡2 BIBSYS|4086783‏
996 ‎‡2 DBC|87097992458768‏
996 ‎‡2 ISNI|0000000041636014‏
996 ‎‡2 BNF|12362505‏
996 ‎‡2 NKC|jo20241241924‏
996 ‎‡2 DNB|1057444251‏
996 ‎‡2 B2Q|0000826939‏
996 ‎‡2 LC|n 96116867‏
996 ‎‡2 NUKAT|n 2010117978‏
996 ‎‡2 DNB|1349755788‏
996 ‎‡2 ISNI|0000000140663800‏
996 ‎‡2 CAOONL|ncf11922657‏
996 ‎‡2 J9U|987008729359005171‏
996 ‎‡2 BNF|16223127‏
996 ‎‡2 KRNLK|KAC200806765‏
996 ‎‡2 ISNI|0000000084142268‏
996 ‎‡2 LC|n 91129854‏
996 ‎‡2 CAOONL|ncf10951097‏
996 ‎‡2 NII|DA06410694‏
996 ‎‡2 NLA|000035837703‏
996 ‎‡2 BIBSYS|5015536‏
996 ‎‡2 BNF|12420622‏
996 ‎‡2 DNB|1160635811‏
996 ‎‡2 J9U|987007417940605171‏
996 ‎‡2 NII|DA13532159‏
996 ‎‡2 LC|no2016163804‏
996 ‎‡2 LIH|LNB:C_u__s__t_;=C_p_‏
996 ‎‡2 ISNI|0000000083665438‏
996 ‎‡2 RERO|A027273512‏
996 ‎‡2 PLWABN|9810615475305606‏
996 ‎‡2 ISNI|0000000027684458‏
996 ‎‡2 DNB|1332733638‏
996 ‎‡2 BIBSYS|90808466‏
996 ‎‡2 DNB|172443598‏
996 ‎‡2 LC|no2010164646‏
996 ‎‡2 SUDOC|191743402‏
996 ‎‡2 SUDOC|192421832‏
996 ‎‡2 NKC|xx0142698‏
996 ‎‡2 LC|n 2011001149‏
996 ‎‡2 DNB|135900131‏
996 ‎‡2 BIBSYS|99064130‏
996 ‎‡2 RERO|A012405752‏
996 ‎‡2 NUKAT|n 2014048912‏
996 ‎‡2 SUDOC|250166607‏
996 ‎‡2 BIBSYS|90311096‏
996 ‎‡2 LC|nb2011023268‏
996 ‎‡2 NII|DA11529095‏
996 ‎‡2 SUDOC|184482186‏
996 ‎‡2 LC|no2008038225‏
996 ‎‡2 SUDOC|053446682‏
996 ‎‡2 CAOONL|ncf11902222‏
996 ‎‡2 ISNI|0000000034517156‏
996 ‎‡2 ISNI|0000000110565126‏
996 ‎‡2 NTA|071941711‏
996 ‎‡2 SUDOC|234578769‏
996 ‎‡2 LNB|LNC10-000176013‏
996 ‎‡2 ISNI|0000000499992168‏
996 ‎‡2 DNB|1123816476‏
996 ‎‡2 DNB|113990387X‏
996 ‎‡2 ISNI|0000000502696571‏
996 ‎‡2 LC|no2016161666‏
996 ‎‡2 CAOONL|ncf10165017‏
996 ‎‡2 SUDOC|249674564‏
996 ‎‡2 LC|n 2019001282‏
996 ‎‡2 ISNI|0000000114671049‏
996 ‎‡2 BIBSYS|90322363‏
996 ‎‡2 LC|n 2006091685‏
996 ‎‡2 ISNI|0000000486521543‏
996 ‎‡2 LC|no2019061338‏
996 ‎‡2 B2Q|0001534105‏
996 ‎‡2 NTA|074904671‏
996 ‎‡2 DNB|1178742024‏
996 ‎‡2 LC|no2007012078‏
996 ‎‡2 ISNI|0000000028931238‏
996 ‎‡2 NTA|097157880‏
996 ‎‡2 BNF|12072572‏
996 ‎‡2 ISNI|0000000053470293‏
996 ‎‡2 BNF|13574342‏
996 ‎‡2 DNB|1157180426‏
996 ‎‡2 ISNI|0000000081670735‏
996 ‎‡2 BNC|981058612368106706‏
996 ‎‡2 LC|n 86080094‏
996 ‎‡2 LC|nr2006007980‏
996 ‎‡2 ISNI|0000000024846386‏
996 ‎‡2 SUDOC|16095732X‏
996 ‎‡2 JPG|500071584‏
996 ‎‡2 NLA|000035663205‏
996 ‎‡2 RERO|A021995701‏
996 ‎‡2 NTA|253190630‏
996 ‎‡2 SUDOC|029009367‏
996 ‎‡2 LC|n 90639878‏
996 ‎‡2 BNF|17815512‏
996 ‎‡2 LC|n 95055123‏
996 ‎‡2 BNF|14546482‏
996 ‎‡2 LC|n 2016065699‏
996 ‎‡2 J9U|987007456580005171‏
996 ‎‡2 N6I|vtls000276318‏
996 ‎‡2 ISNI|0000000076818336‏
996 ‎‡2 LC|no2010150441‏
996 ‎‡2 ISNI|0000000384205806‏
996 ‎‡2 ISNI|0000000055006312‏
996 ‎‡2 CAOONL|ncf11471008‏
996 ‎‡2 ISNI|0000000366168482‏
996 ‎‡2 ISNI|0000000114755920‏
996 ‎‡2 LC|no2011149461‏
996 ‎‡2 RERO|A027273495‏
996 ‎‡2 LC|no 95027634‏
996 ‎‡2 RERO|A027273648‏
996 ‎‡2 NKC|jx20100609006‏
996 ‎‡2 NTA|073545406‏
996 ‎‡2 LC|no2019020125‏
996 ‎‡2 NII|DA01602789‏
996 ‎‡2 NDL|01122346‏
996 ‎‡2 J9U|987007281046605171‏
996 ‎‡2 DNB|1061013545‏
996 ‎‡2 NII|DA12066210‏
996 ‎‡2 SUDOC|067637051‏
996 ‎‡2 DBC|87097969076645‏
996 ‎‡2 BLBNB|000477154‏
996 ‎‡2 NII|DA05665113‏
996 ‎‡2 LC|n 2019026629‏
996 ‎‡2 LC|n 85029760‏
996 ‎‡2 LC|n 2017040761‏
996 ‎‡2 NUKAT|n 2003096572‏
996 ‎‡2 ISNI|0000000101824974‏
996 ‎‡2 BNF|14024866‏
996 ‎‡2 LC|nb2010004848‏
996 ‎‡2 LC|n 85230210‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏